🟢 Alvotech is trading 6.43% up today as FDA-approved process more than doubles SIMLANDI output

Alvotech is trading at ISK 662.00, up 6.43%, after FDA approval of a new SIMLANDI manufacturing process that more than doubles output per batch.

• Alvotech said the process frees manufacturing capacity to support demand across its biosimilar portfolio.
• The announcement was issued at 4:30 a.m. ET, before the Iceland session opened.